← All companies

MRMD

MariMed Inc.

MRMD OTC Medicinal Chemicals & Botanical Products EDGAR ↗

$0.06

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$25.2M

Revenue (TTM)

$161M

Net income (TTM)

-$12.8M

EPS (TTM)

$-0.04

P/E ratio

—

Dividend yield

—

Free cash flow

$6.53M

Cash

$7.94M

Total assets

$201M

Gross margin

36.0%

52-week range

$0.06 – $0.23

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 8, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Results of operations (earnings release) Mar 11, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Amended charter or bylaws Mar 2, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Results of operations (earnings release) Mar 5, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Director or officer change Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Shareholder vote results Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Mar 7, 2024 8-K Results of operations (earnings release) Mar 6, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Other events Nov 20, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Director or officer change Nov 3, 2023 10-Q Quarter ended 2023-06-30 Aug 4, 2023 8-K Results of operations (earnings release) Aug 2, 2023 8-K Shareholder vote results Jun 12, 2023 10-Q Quarter ended 2023-03-31 May 9, 2023 8-K Results of operations (earnings release) May 8, 2023 8-K Director or officer change; Other events Apr 17, 2023 10-K/A Fiscal year ended 2022-12-31 Mar 6, 2023 8-K Amended charter or bylaws Mar 6, 2023 10-K Fiscal year ended 2022-12-31 Mar 3, 2023 8-K Results of operations (earnings release) Mar 1, 2023 8-K Entered a material agreement; Took on a direct financial obligation; Other events Jan 24, 2023